AI was used to translate publications into English, extract data from published studies, and proofread the manuscript
The American Journal of Clinical Nutrition , 87(1), 155S158S
Diana Douglas Person Health Access supports strategic inclusion of drugs in CalRx that can best be targeted to both bring down consumer costs and increase access
The good news, Dexcom CGM is accessible to more people with diabetes now than ever before, and can be an ideal complement to starting, changing, or adjusting GLP-1 medications
Together, the two studies point toward a more nuanced understanding of how GLP-1 drugs work, and who benefits most
Int Immunopharmacol 85:106610 Ilan Y (2016) Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease